Insider · CIK 0001734032

Schaffnit Jeffrey R.

Reports to the SEC for 1 company · DUBLIN, L2

Transactions

Companies

Filings

CIK

0001734032

Forms 4 and 5

Insider transactions

2 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2018-05-24	ITRMIterum Therapeutics plc · Stock Option (Right to Buy)A Award	Chief Commercial Officer	AAward	+25.5K sh	—	—	25,461
2018-05-24	ITRMIterum Therapeutics plc · Stock Option (Right to Buy)A Award	Chief Commercial Officer	AAward	+6,365 sh	—	—	6,365

C/O ITERUM THERAPEUTICS PLC, BLK 2 FL. 3, HARCOURT CENTRE, HARCOURT ST.

DUBLIN, L2, 2